Details of Disease

General Information of Disease (ID: DISK96WQ)

• Disease Name: Flavivirus infection
• Disease Class: 1C80: Viral encephalitis
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISK96WQ: Flavivirus infection
• ICD Code: ICD-11: ICD-11: 1C80

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 4 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Encepur	DME1IHK	Phase 3	NA	[1]
Prophylactic dengue fever vaccine	DMZPZMN	Phase 2	NA	[2]
PTX-022	DM5D5OA	Phase 2	NA	[3]
TD-101	DMJ3KPO	Phase 2	siRNA drug	[4]

This Disease is Treated as An Indication in 1 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
MVA-BN DF	DMDJQ7O	Preclinical	NA	[5]

This Disease is Treated as An Indication in 3 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
4SC-302	DMH2Q94	Investigative	NA	[6]
IPN-200	DM085Y8	Investigative	NA	[6]
Revax-TBE	DM43NX0	Investigative	NA	[6]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] ClinicalTrials.gov (NCT00161824) Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR. U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT00370682) A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand. U.S. National Institutes of Health.
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [4] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [5] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014474)
• [6] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.